Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...

Children who go on to develop pediatric-onset MS have more emergency department visits than their peers, starting years ...

Secondary progressive multiple sclerosis (SPMS) can be active or inactive. Learn about the differences and how it impacts treatment.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

RTE viewers were all up in the air after The Traitors Ireland ended on a “quality” cliffhanger. The new RTE series, that has ...

Sophie Korevaar, 41, who has multiple sclerosis, wants the choice of assisted dying if the time comes and believes it will ...

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...

Immunic receives US patent protecting vidofludimus calcium's dose strengths in progressive multiple sclerosis: New York Wednesday, September 10, 2025, 13:00 Hrs [IST] Immunic, Inc ...

Comprehensive Intellectual Property Strategy Secures Protection Into 2041 in the U.S., Unless Extended Further – Specifically, the resulting patent covers dose strengths associated with lead asset, ...

A man planning a fundraising challenge following his wife's multiple sclerosis (MS) diagnosis has said he realised he had to ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, ...